Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China
· Delayed Price · Currency is CNY 23.63
-0.37 (-1.54%)
At close: Jun 5, 2025, 2:57 PM CST
SHA:688217 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | -12.94 | -15.76 | 7.93 | 40.47 | 47.33 | 38.71 | Upgrade
|
| Depreciation & Amortization | 43.39 | 43.39 | 44.4 | 35.73 | 37.52 | 28.39 | Upgrade
|
| Other Amortization | 3.27 | 3.27 | 1.18 | 2.77 | 4.06 | 4.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.12 | -0.12 | -0.84 | 0.01 | 0.1 | -0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | 16.67 | 16.67 | 7.64 | 14.16 | -1.5 | 0.95 | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.49 | -2.49 | -3.01 | -3.1 | -1.47 | -0.22 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.65 | 6.65 | 5.03 | 9.56 | 1.06 | 1.01 | Upgrade
|
| Other Operating Activities | -12.4 | -8.6 | -10.87 | 21.64 | -5.28 | 4.84 | Upgrade
|
| Change in Accounts Receivable | 14.49 | 14.49 | 182.51 | -101.21 | 2.87 | -20.9 | Upgrade
|
| Change in Inventory | 9.79 | 9.79 | -15.93 | -16.97 | -10.8 | 8.03 | Upgrade
|
| Change in Accounts Payable | 2.86 | 2.86 | -167.29 | 64.84 | 3.62 | 6.42 | Upgrade
|
| Change in Other Net Operating Assets | -4.1 | -4.1 | 2.15 | 8.84 | - | - | Upgrade
|
| Operating Cash Flow | 59 | 59.98 | 45.1 | 73.07 | 77.97 | 70.11 | Upgrade
|
| Operating Cash Flow Growth | 194.93% | 33.00% | -38.28% | -6.28% | 11.20% | 500.25% | Upgrade
|
| Capital Expenditures | -37.61 | -39.41 | -109.09 | -106.57 | -95.6 | -52.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 0.14 | 0.22 | - | 1.39 | 1.69 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 2.43 | Upgrade
|
| Investment in Securities | -30.12 | -21.98 | 3.56 | 109.03 | -188.56 | -1.47 | Upgrade
|
| Other Investing Activities | 2.06 | 1.99 | 2.74 | 4.58 | 4.19 | 0.16 | Upgrade
|
| Investing Cash Flow | -65.54 | -59.27 | -102.58 | 7.04 | -278.57 | -49.33 | Upgrade
|
| Long-Term Debt Issued | - | - | 20 | 1.35 | - | - | Upgrade
|
| Total Debt Issued | - | - | 20 | 1.35 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -23.08 | -7.22 | -5.87 | -4.62 | -10.9 | Upgrade
|
| Total Debt Repaid | -39.33 | -23.08 | -7.22 | -5.87 | -4.62 | -10.9 | Upgrade
|
| Net Debt Issued (Repaid) | -39.33 | -23.08 | 12.78 | -4.52 | -4.62 | -10.9 | Upgrade
|
| Issuance of Common Stock | - | - | 8.97 | - | 224.04 | - | Upgrade
|
| Common Dividends Paid | -0.57 | -0.62 | -10.4 | -0.01 | -0.02 | - | Upgrade
|
| Other Financing Activities | 13.93 | - | - | - | -27.59 | 0.06 | Upgrade
|
| Financing Cash Flow | -25.98 | -23.7 | 11.36 | -4.53 | 191.8 | -10.84 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.18 | 0.66 | 0.84 | 4.69 | -1.54 | -4.67 | Upgrade
|
| Net Cash Flow | -32.7 | -22.33 | -45.29 | 80.26 | -10.35 | 5.27 | Upgrade
|
| Free Cash Flow | 21.39 | 20.57 | -64 | -33.5 | -17.63 | 17.97 | Upgrade
|
| Free Cash Flow Margin | 9.19% | 8.49% | -24.79% | -7.90% | -6.06% | 6.31% | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.36 | -1.13 | -0.60 | -0.35 | 0.43 | Upgrade
|
| Cash Income Tax Paid | 11.86 | 9.99 | 17.59 | 1.16 | -1.81 | 8.48 | Upgrade
|
| Levered Free Cash Flow | 21.52 | 25.32 | -63.29 | -58.2 | -31.58 | -16.05 | Upgrade
|
| Unlevered Free Cash Flow | 22.19 | 25.87 | -62.77 | -57.86 | -31.28 | -16.01 | Upgrade
|
| Change in Net Working Capital | -27.6 | -34.69 | -5.07 | 41.82 | -5.84 | 20.28 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.